BlackRock Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $1.05M | Buy |
151,002
+363
| +0.2% | +$2.52K | ﹤0.01% | 2659 |
|
2016
Q3 | $767K | Sell |
150,639
-410
| -0.3% | -$2.09K | ﹤0.01% | 2810 |
|
2016
Q2 | $902K | Buy |
151,049
+144,722
| +2,287% | +$864K | ﹤0.01% | 2696 |
|
2016
Q1 | $29K | Sell |
6,327
-202
| -3% | -$926 | ﹤0.01% | 3285 |
|
2015
Q4 | $29K | Buy |
6,529
+211
| +3% | +$937 | ﹤0.01% | 3338 |
|
2015
Q3 | $20K | Hold |
6,318
| – | – | ﹤0.01% | 3429 |
|
2015
Q2 | $19K | Sell |
6,318
-97,272
| -94% | -$293K | ﹤0.01% | 3434 |
|
2015
Q1 | $306K | Buy |
103,590
+3,845
| +4% | +$11.4K | ﹤0.01% | 3115 |
|
2014
Q4 | $443K | Buy |
99,745
+464
| +0.5% | +$2.06K | ﹤0.01% | 3059 |
|
2014
Q3 | $511K | Buy |
99,281
+2,209
| +2% | +$11.4K | ﹤0.01% | 2948 |
|
2014
Q2 | $510K | Buy |
+97,072
| New | +$510K | ﹤0.01% | 3018 |
|